SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-016944
Filing Date
2019-08-29
Accepted
2019-08-29 16:30:23
Documents
3
Period of Report
2019-08-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k082719_soligenix.htm 8-K 16678
2 PRESS RELEASE DATED AUGUST 27, 2019 ISSUED BY SOLIGENIX, INC. f8k082719ex99-1_soligenix.htm EX-99.1 26143
3 GRAPHIC image_001.jpg GRAPHIC 6473
  Complete submission text file 0001213900-19-016944.txt   53247
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 191066724
SIC: 2834 Pharmaceutical Preparations